HK1205531A1 - Mesenchymal stem cells and uses therefor - Google Patents
Mesenchymal stem cells and uses thereforInfo
- Publication number
- HK1205531A1 HK1205531A1 HK15106165.9A HK15106165A HK1205531A1 HK 1205531 A1 HK1205531 A1 HK 1205531A1 HK 15106165 A HK15106165 A HK 15106165A HK 1205531 A1 HK1205531 A1 HK 1205531A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- stem cells
- mesenchymal stem
- methods
- animal
- uses therefor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55511804P | 2004-03-22 | 2004-03-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1205531A1 true HK1205531A1 (en) | 2015-12-18 |
Family
ID=46060822
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15106165.9A HK1205531A1 (en) | 2004-03-22 | 2015-06-29 | Mesenchymal stem cells and uses therefor |
| HK15106166.8A HK1205677A1 (en) | 2004-03-22 | 2015-06-29 | Mesenchymal stem cells and uses therefor |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15106166.8A HK1205677A1 (en) | 2004-03-22 | 2015-06-29 | Mesenchymal stem cells and uses therefor |
Country Status (6)
| Country | Link |
|---|---|
| JP (8) | JP6114500B2 (es) |
| AT (1) | ATE556134T1 (es) |
| CA (3) | CA2868733C (es) |
| ES (7) | ES2708627T3 (es) |
| HK (2) | HK1205531A1 (es) |
| TR (1) | TR201901268T4 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR201901268T4 (tr) * | 2004-03-22 | 2019-02-21 | Mesoblast Int Sarl | Mezenkimal kök hücreleri ve bunların kullanımları. |
| CA2873968A1 (en) * | 2012-05-16 | 2014-06-26 | Kennedy Krieger Institute, Inc. | Stem cells as an individualized maternal therapy for prevention of prematurity |
| JP2016210730A (ja) * | 2015-05-08 | 2016-12-15 | 上田 実 | 医薬組成物及びその製造方法並びに医薬品 |
| CN109952371A (zh) | 2016-11-15 | 2019-06-28 | 株式会社钟化 | 包含来自胎儿附属物的间充质系干细胞的细胞群、其制备方法、以及医药组合物 |
| JP7454379B2 (ja) | 2017-12-28 | 2024-03-22 | 株式会社カネカ | 接着性幹細胞を含む細胞集団とその製造方法、及び医薬組成物 |
| EP3984596A4 (en) | 2019-06-14 | 2023-06-21 | Kaneka Corporation | POPULATION OF CELLS COMPRISING MESENCHYMATOUS CELLS, PHARMACEUTICAL COMPOSITION COMPRISING THEM AND METHOD FOR PRODUCTION THEREOF |
| AU2020330745A1 (en) * | 2019-08-15 | 2022-03-24 | Nextcell Pharma Ab | Allogeneic composition for treatment of CNS disorders |
| CN113813288B (zh) * | 2021-08-11 | 2024-02-13 | 谢岩 | 间充质干细胞及包含其的组合物用于制备治疗烧伤难愈创面的药物的用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0651641B2 (ja) * | 1983-08-29 | 1994-07-06 | 株式会社ミドリ十字 | ガンマ・インターフェロン組成物 |
| EP0302862A1 (en) * | 1986-03-17 | 1989-02-15 | Schering Corporation | Treatment of cancers with gamma interferon |
| WO1995034320A2 (en) * | 1994-06-07 | 1995-12-21 | Regents Of The University Of Minnesota | Methods for inhibiting antigen specific t cell responses |
| US6497875B1 (en) * | 1996-04-26 | 2002-12-24 | Case Western Reserve University | Multilayer skin or dermal equivalent having a layer containing mesenchymal stem cells |
| US6368636B1 (en) * | 1998-03-18 | 2002-04-09 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| ATE316795T1 (de) * | 1998-03-18 | 2006-02-15 | Osiris Therapeutics Inc | Mesenchymale stammzellen für die prävention und behandlung von immunantworten bei transplantationen |
| DK1066060T3 (da) * | 1998-04-03 | 2003-11-24 | Osiris Therapeutics Inc | Mesenkymale stamceller som immunsuppresive midler |
| AU2925401A (en) * | 2000-01-19 | 2001-07-31 | Parkash S Gill | Methods and compositions for antisense vegf oligonucleotides |
| DE60143517D1 (de) * | 2000-04-25 | 2011-01-05 | Osiris Therapeutics Inc | Wiederherstellung der gelenken mit mesenchymalen stammzellen |
| NZ533987A (en) * | 2002-02-01 | 2007-04-27 | Schering Corp | Uses of mammalian cytokine; agonists and antagonists for modulating antigen presenting cell priming of T cells |
| JP3897343B2 (ja) * | 2002-08-01 | 2007-03-22 | 株式会社林原生物化学研究所 | 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質 |
| US20040258670A1 (en) * | 2002-12-05 | 2004-12-23 | Case Western Reserve University | Cell-based therapies for ischemia |
| TR201901268T4 (tr) * | 2004-03-22 | 2019-02-21 | Mesoblast Int Sarl | Mezenkimal kök hücreleri ve bunların kullanımları. |
| EP2298863B1 (en) * | 2004-03-22 | 2015-07-22 | Mesoblast International Sàrl | Mesenchymal stem cells and uses therefor |
-
2005
- 2005-03-15 TR TR2019/01268T patent/TR201901268T4/tr unknown
- 2005-03-15 ES ES14172800T patent/ES2708627T3/es active Active
- 2005-03-15 ES ES10011225.9T patent/ES2544689T3/es active Active
- 2005-03-15 ES ES14172807T patent/ES2657382T5/es active Active
- 2005-03-15 CA CA2868733A patent/CA2868733C/en active Active
- 2005-03-15 CA CA3135582A patent/CA3135582A1/en active Pending
- 2005-03-15 ES ES05725577T patent/ES2385450T3/es active Active
- 2005-03-15 AT AT05725577T patent/ATE556134T1/de active
- 2005-03-15 ES ES10011223.4T patent/ES2643030T3/es active Active
- 2005-03-15 ES ES10011224.2T patent/ES2643076T3/es active Active
- 2005-03-15 ES ES10011226.7T patent/ES2645018T3/es active Active
- 2005-03-15 CA CA2934682A patent/CA2934682C/en active Active
-
2012
- 2012-03-15 JP JP2012058539A patent/JP6114500B2/ja active Active
-
2014
- 2014-11-28 JP JP2014241859A patent/JP5997237B2/ja active Active
-
2015
- 2015-06-29 HK HK15106165.9A patent/HK1205531A1/xx unknown
- 2015-06-29 HK HK15106166.8A patent/HK1205677A1/xx unknown
-
2017
- 2017-01-13 JP JP2017003854A patent/JP6382360B2/ja active Active
- 2017-08-10 JP JP2017155229A patent/JP6757300B2/ja active Active
-
2018
- 2018-10-09 JP JP2018190636A patent/JP6757383B2/ja active Active
-
2020
- 2020-03-18 JP JP2020047240A patent/JP7033159B2/ja active Active
-
2021
- 2021-08-30 JP JP2021140167A patent/JP2021191771A/ja active Pending
-
2023
- 2023-02-20 JP JP2023023996A patent/JP2023065486A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018009002A (ja) | 2018-01-18 |
| ES2643030T3 (es) | 2017-11-21 |
| ES2385450T3 (es) | 2012-07-25 |
| CA2934682A1 (en) | 2005-10-06 |
| JP6382360B2 (ja) | 2018-08-29 |
| CA2868733C (en) | 2019-12-17 |
| JP7033159B2 (ja) | 2022-03-09 |
| CA2868733A1 (en) | 2005-10-06 |
| TR201901268T4 (tr) | 2019-02-21 |
| JP6757300B2 (ja) | 2020-09-16 |
| ES2645018T3 (es) | 2017-12-01 |
| JP2021191771A (ja) | 2021-12-16 |
| JP2020111591A (ja) | 2020-07-27 |
| JP2019014747A (ja) | 2019-01-31 |
| ES2708627T3 (es) | 2019-04-10 |
| JP2012176948A (ja) | 2012-09-13 |
| CA2934682C (en) | 2021-12-07 |
| ES2657382T3 (es) | 2018-03-05 |
| JP2023065486A (ja) | 2023-05-12 |
| ES2544689T3 (es) | 2015-09-02 |
| JP5997237B2 (ja) | 2016-09-28 |
| ES2643076T3 (es) | 2017-11-21 |
| ATE556134T1 (de) | 2012-05-15 |
| HK1205677A1 (en) | 2015-12-24 |
| JP2017080507A (ja) | 2017-05-18 |
| JP6757383B2 (ja) | 2020-09-16 |
| JP6114500B2 (ja) | 2017-04-12 |
| CA3135582A1 (en) | 2005-10-06 |
| ES2657382T5 (es) | 2021-07-12 |
| JP2015061862A (ja) | 2015-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1205677A1 (en) | Mesenchymal stem cells and uses therefor | |
| EP2298861A3 (en) | Mesenchymal stem cells and uses therefor | |
| WO2008116157A3 (en) | Mesenchymal stem cells and uses therefor | |
| EA200700175A1 (ru) | Композиции и способы лечения воспалительных заболеваний | |
| ATE489957T1 (de) | Mittel zur behandlung von entzündlichen erkrankungen | |
| MX2007004551A (es) | Compuestos tiadiazol y metodos de uso. | |
| TW200738657A (en) | Thiazole compounds and methods of use | |
| TW200732347A (en) | VEGF analogs and methods of use | |
| SG158112A1 (en) | Hepatocyte growth factor (hgf) binding proteins | |
| BR0308928A (pt) | Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular | |
| CY1118073T1 (el) | Συνθεσεις και μεθοδοι για την αυξηση της δρασης της τελομερασης | |
| HK1122803A1 (es) | ||
| AR061170A1 (es) | Proteinas que se unen con el factor de crecimiento de hepatocitos (hgf) | |
| TW200833330A (en) | Substituted dihydropyrazolones and their use | |
| MY158100A (en) | 6,9-disubstituted purine derivatives and their use for treating skin | |
| DE602005026866D1 (de) | Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen | |
| ITMI20041550A1 (it) | Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide | |
| MX2007010484A (es) | Moleculas y metodos para usarlas para tratar enfermedades asociadas con mcp-1/ccr2. | |
| HK1112721A1 (en) | Tissue disruption treatment and composition for use thereof | |
| CY1111353T1 (el) | Χρηση ενωσεων κααλαλιδης για την παραγωγη φαρμακου για τη θεραπεια της ψωριασης | |
| DE602006011959D1 (de) | Na+, k+-atpase-expression bei zervixdysplasie und -krebs | |
| MX2011009277A (es) | Composicion de leucocito activada. | |
| WO2007055760A3 (en) | Protein composition for promoting wound healing and skin regeneration | |
| WO2011091154A3 (en) | Use of human erythrocytes for prevention and treatment of cancer dissemination and growth | |
| EA200701598A1 (ru) | Способ и композиция для восстановления эпителиальных и других клеток и тканей |